Custom Executive Partnering Briefing

Bespoke dealmaking intelligence, applied directly to your business

Current Partnering Executive Briefings provide senior decision-makers with a customized analysis of the partnering landscape most relevant to their company, technology, pipeline or commercial objectives.

Each briefing applies Current Partnering’s proprietary pharmaceutical, biotech and broader life science dealmaking intelligence to a clearly defined business question. It brings together relevant comparable transactions, financial benchmarks, active dealmakers, potential partners and strategic market trends in a focused, executive-level deliverable.

The result is a practical source of evidence to support business development, licensing, commercialisation, negotiation planning and investment decisions.

Request my free Briefing Scope and Table of Contents

Intelligence tailored to your strategic priorities

Unlike a standard market report, our Executive Partnering Briefings are developed around your specific business, assets and objectives. The scope can be customized to address questions such as:

• Which companies are actively partnering in our target market?
• Who are the most relevant potential partners for our technology or pipeline?
• How have comparable deals been structured and valued?
• What upfront payments, milestones, royalties and rights structures are being agreed?
• Which transactions provide the strongest benchmarks for an upcoming negotiation?
• How is partnering activity evolving across a particular therapy area, technology or deal type?
• Which companies are expanding into, investing in or exiting the market?
• What strategic trends should inform our partnering or commercialisation strategy?

Every briefing is designed to answer a defined commercial question rather than provide generic market commentary.

What your Executive Partnering Brief may include

The content and depth of each briefing will depend on your objectives. A customized scope may include:

Comparable transaction analysis

Identification and analysis of relevant licensing, collaboration, acquisition, option, co-development, commercialisation or research agreements.

Deal structure benchmarking

Review of disclosed upfront payments, milestone structures, royalties, equity investments, rights allocation, territory splits and development responsibilities.

Potential partner identification

Identification of companies with a demonstrated strategic interest in the relevant therapy area, technology, modality, asset type or stage of development.

Active dealmaker analysis

Assessment of the organisations completing the greatest number of relevant transactions, including their recent partnering activity and strategic direction.

Strategic market trends

Analysis of changes in deal volume, deal type, company participation, technology focus and transaction structure.

Landmark and precedent transactions

Selection of significant transactions that may provide useful strategic, financial or contractual precedents.

Termsheet and contract intelligence

Analysis of recurring contractual themes and deal terms, supported by contract documents where these are publicly available.

Executive observations

Practical conclusions highlighting the implications of the evidence for your business development, licensing, commercialisation or negotiation strategy.

Designed for senior decision makers

Executive Partnering Briefings are developed for corporate leaders who need concise, commercially relevant evidence to support important decisions.

They are particularly valuable for:

• CEOs, CBOs and CSOs
• Business Development and Licensing executives
• Corporate Development teams
• Commercial and Portfolio Strategy leaders
• Alliance Management executives
• Technology Transfer and Commercialisation teams
• Investment and transaction committees
• Board members and senior advisers

The analysis can be prepared for an individual executive, a project team, an investment committee or a wider leadership group.

Common briefing applications

Partner identification

Build a prioritised view of companies that have the strategic fit, transaction history and market interest to become potential partners.

Deal benchmarking

Assess how comparable transactions have been structured and valued to support internal valuation, negotiation preparation and approval processes.

Licensing strategy

Evaluate potential deal structures, rights models, development responsibilities and financial terms before entering discussions.

Commercialisation planning

Compare partnering, co-development, regional licensing and independent commercialisation options.

Market entry analysis

Understand the competitive and partnering environment surrounding a new therapy area, technology platform or geographic market.

Transaction preparation

Provide management teams, boards and advisers with evidence to support an upcoming licensing process, acquisition, collaboration or strategic review.

Portfolio prioritisation

Assess where partnering activity, market demand and transaction precedent may support the development or out-licensing of particular assets.

Built on over twenty years of partnering intelligence

Current Partnering has spent over twenty years analysing pharmaceutical, biotech and broader life science transactions.

Our proprietary intelligence includes:

• Analyst-curated deal records
• Detailed transaction classifications
• Financial term benchmarking
• Analyst-written termsheet summaries
• Company and dealmaker activity
• Therapy area and technology trends
• Contract links where publicly available
• Structured analysis of deal rights, responsibilities and economics

This evidence base allows us to move beyond general market research and focus on the transactions, companies and deal terms most relevant to your commercial question.

The report provides the evidence. The briefing applies it to your business.

Current Partnering reports provide detailed market evidence across therapy areas, technologies and transaction types. A custom Executive Partnering Briefing builds on that intelligence by applying it directly to your company, platform, pipeline or strategic objectives.

Where appropriate, an Executive Partnering Briefing can be commissioned alongside a Current Partnering report, ensuring that your team receives both:

• A comprehensive source of market and transaction intelligence
• A tailored executive analysis focused on your specific business question

This combination gives leadership teams access to the wider market evidence while also highlighting the transactions, companies, benchmarks and trends that matter most to their immediate priorities.

A briefing shaped around your question

There is no fixed format or page count. Each briefing is scoped according to:

• The strategic question you need to answer
• The therapy area, technology or market of interest
• The type of transactions being assessed
• The level of financial and contractual analysis required
• The number of companies, assets or comparable deals involved
• The intended audience and decision-making process
• Your preferred timeframe

The final deliverable will be structured to provide the level of evidence and analysis required to address your objectives clearly and effectively.

How the process works

1. Submit your inquiry

Tell us about your company, area of interest and the commercial question you would like the briefing to address.

2. Receive a proposed scope

We will prepare a free-of-charge, no-obligation table of contents and proposed scope outlining the analysis, deliverables and areas of investigation we recommend.

3. Refine the briefing

We will work with you to ensure that the scope reflects your priorities, intended audience and decision-making requirements.

4. Commission the analysis

Once the scope is agreed, our analysts will prepare the Executive Partnering Brief using Current Partnering’s proprietary deal and market intelligence.

5. Apply the findings

Use the briefing to support partner selection, deal benchmarking, negotiation planning, management discussions, board presentations or strategic decision-making.

Request your free proposed scope

Tell us what your organisation is assessing and the question you need to answer and we will provide a free, no-obligation proposed table of contents and briefing scope showing how a customised Executive Partnering Brief could support your objectives.

In order for us to complete your requested scope as efficiently as possible, please provide us with the following information in the inquiry form:

• Name
• Job title
• Company
• Business email address (not Gmail, hotmail etc)
• Therapy area or technology of interest
• Type of transaction or strategic question
• Brief description of the required analysis
• Preferred timeframe
• Relevant Current Partnering report, if applicable

Request My Free Briefing Scope

There is no charge for the initial table of contents and proposed scope, and no obligation to proceed.

Frequently asked questions

What is an Executive Partnering Brief?

An Executive Partnering Brief is a customised analysis that applies Current Partnering’s dealmaking intelligence to a specific company, asset, technology, market or strategic question.

How is it different from a Current Partnering report?

A Current Partnering report provides comprehensive market evidence for a defined therapy area, technology or deal type. An Executive Partnering Brief selects and interprets the evidence most relevant to your organisation and objectives.

Can the briefing focus on our company or pipeline?

Yes. The analysis can be developed around your company, individual assets, technology platform, development pipeline, partnering strategy or commercial objectives.

Can you identify potential partners?

Yes. A briefing can identify and assess companies with relevant deal activity, strategic interests, market presence, pipeline priorities or partnering behaviour.

Can you benchmark financial deal terms?

Yes. Where terms have been disclosed, the briefing can analyse upfront payments, milestones, royalties, equity investments and other financial components of comparable transactions.

Can you analyse contract terms?

Where relevant contract documents are available, the briefing can examine recurring termsheet themes, rights provisions and contractual structures.

Is there a standard page length?

No. Each briefing is as detailed as required to answer the agreed commercial question.

Do I need to purchase a report as well?

Not necessarily. A briefing may be commissioned independently, or provided alongside a relevant Current Partnering report. We will recommend the most appropriate approach in the proposed scope.

Is there a charge for the initial scope?

No. The proposed table of contents and briefing scope are provided free of charge and without obligation.

Discuss your strategic question with us

Whether you are identifying potential partners, benchmarking an upcoming transaction, evaluating licensing options or preparing for negotiations, a customised Executive Partnering Briefing can provide the evidence needed to support a more informed decision.

Complete our inquiry form and we will prepare a free proposed table of contents and scope tailored to your requirements.

Request My Free Briefing Scope